Analysis of ganciclovir-resistant human herpesvirus 6B clinical isolates using quenching probe PCR methodology

Hiroyuki Hiramatsu, Ryota Suzuki, Shigeki Yamada, Masaru Ihira, Yuji Isegawa, Yoshiki Kawamura, Erina Matsuoka, Hiroki Miura, Tetsushi Yoshikawa

Research output: Contribution to journalArticle

Abstract

Quenching probe PCR (QP-PCR) analysis was used to determine the frequency of ganciclovir (GCV) resistance among clinical isolates of human herpesvirus 6B (HHV-6B) obtained from patients with primary viral infection and viral reactivation. Forty-two HHV-6B clinical isolates were repeatedly recovered from 15 hematopoietic stem cell transplant (HSCT) recipients, and 20 isolates were recovered from 20 exanthem subitum (ES) patients. Of the 15 HSCT recipients, 9 received GCV during the observation period; however, none of the ES patients were treated with GCV. Two established laboratory strains, Z29 and HST, were used as standards in this study. Regions 1 and 2 of the U69 gene of all of the clinical isolates demonstrated the same melting temperature as regions 1 and 2 of the Z29 strain. For region 3, the melting temperatures of all clinical isolates fell between the melting temperature of the plasmid containing the A462D single nucleotide polymorphism (SNP) and the melting temperature of the Z29 strain, and the melting temperatures profiles of all clinical isolates were similar to the melting temperature profile of the Japanese HST strain. As expected, none of the 20 clinical isolates recovered from the ES patients and the 14 isolates recovered from the HSCT recipients who did not receive GCV treatment carried the six known SNPs associated with GCV resistance. Interestingly, these six SNPs were not detected in the 28 clinical isolates recovered from the 9 HSCT recipients who received GCV. Additional sequence analysis of the U69 gene from the 15 representative isolates from the 15 HSCT recipients identified other SNPs. These SNPs were identical to those identified in the HST strain. Therefore, the rate of emergence of GCV-resistant HHV-6B strains appears to be relatively low, even in HSCT recipients treated with GCV.

Original languageEnglish
Pages (from-to)2618-2624
Number of pages7
JournalAntimicrobial agents and chemotherapy
Volume59
Issue number5
DOIs
Publication statusPublished - 01-05-2015

Fingerprint

Human Herpesvirus 6
Ganciclovir
Hematopoietic Stem Cells
Freezing
Polymerase Chain Reaction
Single Nucleotide Polymorphism
Transplants
Temperature
Exanthema
Virus Diseases
Genes
Sequence Analysis
Transplant Recipients
Plasmids
Observation

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Hiramatsu, Hiroyuki ; Suzuki, Ryota ; Yamada, Shigeki ; Ihira, Masaru ; Isegawa, Yuji ; Kawamura, Yoshiki ; Matsuoka, Erina ; Miura, Hiroki ; Yoshikawa, Tetsushi. / Analysis of ganciclovir-resistant human herpesvirus 6B clinical isolates using quenching probe PCR methodology. In: Antimicrobial agents and chemotherapy. 2015 ; Vol. 59, No. 5. pp. 2618-2624.
@article{b04b24475ca1485aa64f7b10581d4efa,
title = "Analysis of ganciclovir-resistant human herpesvirus 6B clinical isolates using quenching probe PCR methodology",
abstract = "Quenching probe PCR (QP-PCR) analysis was used to determine the frequency of ganciclovir (GCV) resistance among clinical isolates of human herpesvirus 6B (HHV-6B) obtained from patients with primary viral infection and viral reactivation. Forty-two HHV-6B clinical isolates were repeatedly recovered from 15 hematopoietic stem cell transplant (HSCT) recipients, and 20 isolates were recovered from 20 exanthem subitum (ES) patients. Of the 15 HSCT recipients, 9 received GCV during the observation period; however, none of the ES patients were treated with GCV. Two established laboratory strains, Z29 and HST, were used as standards in this study. Regions 1 and 2 of the U69 gene of all of the clinical isolates demonstrated the same melting temperature as regions 1 and 2 of the Z29 strain. For region 3, the melting temperatures of all clinical isolates fell between the melting temperature of the plasmid containing the A462D single nucleotide polymorphism (SNP) and the melting temperature of the Z29 strain, and the melting temperatures profiles of all clinical isolates were similar to the melting temperature profile of the Japanese HST strain. As expected, none of the 20 clinical isolates recovered from the ES patients and the 14 isolates recovered from the HSCT recipients who did not receive GCV treatment carried the six known SNPs associated with GCV resistance. Interestingly, these six SNPs were not detected in the 28 clinical isolates recovered from the 9 HSCT recipients who received GCV. Additional sequence analysis of the U69 gene from the 15 representative isolates from the 15 HSCT recipients identified other SNPs. These SNPs were identical to those identified in the HST strain. Therefore, the rate of emergence of GCV-resistant HHV-6B strains appears to be relatively low, even in HSCT recipients treated with GCV.",
author = "Hiroyuki Hiramatsu and Ryota Suzuki and Shigeki Yamada and Masaru Ihira and Yuji Isegawa and Yoshiki Kawamura and Erina Matsuoka and Hiroki Miura and Tetsushi Yoshikawa",
year = "2015",
month = "5",
day = "1",
doi = "10.1128/AAC.04692-14",
language = "English",
volume = "59",
pages = "2618--2624",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "5",

}

Analysis of ganciclovir-resistant human herpesvirus 6B clinical isolates using quenching probe PCR methodology. / Hiramatsu, Hiroyuki; Suzuki, Ryota; Yamada, Shigeki; Ihira, Masaru; Isegawa, Yuji; Kawamura, Yoshiki; Matsuoka, Erina; Miura, Hiroki; Yoshikawa, Tetsushi.

In: Antimicrobial agents and chemotherapy, Vol. 59, No. 5, 01.05.2015, p. 2618-2624.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Analysis of ganciclovir-resistant human herpesvirus 6B clinical isolates using quenching probe PCR methodology

AU - Hiramatsu, Hiroyuki

AU - Suzuki, Ryota

AU - Yamada, Shigeki

AU - Ihira, Masaru

AU - Isegawa, Yuji

AU - Kawamura, Yoshiki

AU - Matsuoka, Erina

AU - Miura, Hiroki

AU - Yoshikawa, Tetsushi

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Quenching probe PCR (QP-PCR) analysis was used to determine the frequency of ganciclovir (GCV) resistance among clinical isolates of human herpesvirus 6B (HHV-6B) obtained from patients with primary viral infection and viral reactivation. Forty-two HHV-6B clinical isolates were repeatedly recovered from 15 hematopoietic stem cell transplant (HSCT) recipients, and 20 isolates were recovered from 20 exanthem subitum (ES) patients. Of the 15 HSCT recipients, 9 received GCV during the observation period; however, none of the ES patients were treated with GCV. Two established laboratory strains, Z29 and HST, were used as standards in this study. Regions 1 and 2 of the U69 gene of all of the clinical isolates demonstrated the same melting temperature as regions 1 and 2 of the Z29 strain. For region 3, the melting temperatures of all clinical isolates fell between the melting temperature of the plasmid containing the A462D single nucleotide polymorphism (SNP) and the melting temperature of the Z29 strain, and the melting temperatures profiles of all clinical isolates were similar to the melting temperature profile of the Japanese HST strain. As expected, none of the 20 clinical isolates recovered from the ES patients and the 14 isolates recovered from the HSCT recipients who did not receive GCV treatment carried the six known SNPs associated with GCV resistance. Interestingly, these six SNPs were not detected in the 28 clinical isolates recovered from the 9 HSCT recipients who received GCV. Additional sequence analysis of the U69 gene from the 15 representative isolates from the 15 HSCT recipients identified other SNPs. These SNPs were identical to those identified in the HST strain. Therefore, the rate of emergence of GCV-resistant HHV-6B strains appears to be relatively low, even in HSCT recipients treated with GCV.

AB - Quenching probe PCR (QP-PCR) analysis was used to determine the frequency of ganciclovir (GCV) resistance among clinical isolates of human herpesvirus 6B (HHV-6B) obtained from patients with primary viral infection and viral reactivation. Forty-two HHV-6B clinical isolates were repeatedly recovered from 15 hematopoietic stem cell transplant (HSCT) recipients, and 20 isolates were recovered from 20 exanthem subitum (ES) patients. Of the 15 HSCT recipients, 9 received GCV during the observation period; however, none of the ES patients were treated with GCV. Two established laboratory strains, Z29 and HST, were used as standards in this study. Regions 1 and 2 of the U69 gene of all of the clinical isolates demonstrated the same melting temperature as regions 1 and 2 of the Z29 strain. For region 3, the melting temperatures of all clinical isolates fell between the melting temperature of the plasmid containing the A462D single nucleotide polymorphism (SNP) and the melting temperature of the Z29 strain, and the melting temperatures profiles of all clinical isolates were similar to the melting temperature profile of the Japanese HST strain. As expected, none of the 20 clinical isolates recovered from the ES patients and the 14 isolates recovered from the HSCT recipients who did not receive GCV treatment carried the six known SNPs associated with GCV resistance. Interestingly, these six SNPs were not detected in the 28 clinical isolates recovered from the 9 HSCT recipients who received GCV. Additional sequence analysis of the U69 gene from the 15 representative isolates from the 15 HSCT recipients identified other SNPs. These SNPs were identical to those identified in the HST strain. Therefore, the rate of emergence of GCV-resistant HHV-6B strains appears to be relatively low, even in HSCT recipients treated with GCV.

UR - http://www.scopus.com/inward/record.url?scp=84931287842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931287842&partnerID=8YFLogxK

U2 - 10.1128/AAC.04692-14

DO - 10.1128/AAC.04692-14

M3 - Article

C2 - 25691643

AN - SCOPUS:84931287842

VL - 59

SP - 2618

EP - 2624

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 5

ER -